Paper Details

  1. Home
  2. Paper Details

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Author: ClarkW K, EvansB W, MooreD J, WhorwellP J

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Irritable bowel syndrome (IBS) is a complex condition with a wide range of symptoms. Chronic constipation can often mimic IBS with constipation. Current medications for IBS are limited in their effectiveness, often only addressing specific symptoms. Tegaserod is a new medication that works differently, targeting IBS and chronic constipation.
Paper Details　
Original Abstract of the Article :
IBS is a complex disorder that encompasses a wide profile of symptoms. The symptoms of chronic constipation frequently resemble those of constipation-predominant IBS. Current drug treatments for irritable bowel syndrome (IBS) are of limited value. Many target specific symptoms only. Tegaserod, a 5HT...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD003960.pub3

データ提供：米国国立医学図書館（NLM）

Tegaserod: A Novel Approach to Irritable Bowel Syndrome and Chronic Constipation

Irritable bowel syndrome (IBS) and chronic constipation are common gastrointestinal conditions that can significantly impact quality of life. This research focuses on tegaserod, a novel drug targeting the 5HT(4) receptor, as a potential treatment for these conditions. The authors discuss the challenges of existing treatments and highlight the unique mechanism of action of tegaserod, offering a new avenue for managing these disorders.

A New Hope for IBS and Chronic Constipation

Tegaserod, with its unique mechanism of action, presents a promising new approach to managing IBS and chronic constipation. The study highlights the limitations of current treatments and emphasizes the potential of this drug in addressing the symptoms of these conditions. It offers a glimmer of hope for patients seeking effective relief from these challenging gastrointestinal disorders.

Navigating the Digestive Desert

This research is like a refreshing oasis in the vast desert of gastrointestinal disorders. IBS and chronic constipation can be incredibly difficult to manage, making the discovery of tegaserod a potential breakthrough. While further research is needed, this study offers hope for a new and potentially effective treatment for these conditions, potentially leading to better management of digestive health.

Dr. Camel's Conclusion

Imagine a long, arduous trek across a scorching desert. IBS and chronic constipation are like the scorching heat and lack of water that can make this journey unbearably difficult. Tegaserod is like a hidden spring in the desert, offering a potential oasis of relief for those suffering from these conditions. More research is needed to fully understand its benefits, but this study represents a promising step towards a more comfortable journey through the digestive desert.

Date :
  1. Date Completed 2008-01-17
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

17943807

DOI: Digital Object Identifier

10.1002/14651858.CD003960.pub3

Related Literature

Article Analysis
・Effective treatment of irritable bowel syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.